ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1416	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	relapsed ovarian cancer 0.50784 recurrent epithelial ovarian 0.499159 ovarian cancer symptom 0.524517 gynecologic cancer intergroup 0.468129 epithelial ovarian carcinoma 0.585917 chemotherapy 0.476196 Engl J Med 0.538958 advanced ovarian cancer 0.684932 advanced epithelial ovarian 0.546935 ovarian cancer FIGO 0.514859 ovarian cancer. 0.501481 [PUBMED Abstract] 0.522867 primary peritoneal cancer 0.467281 ovarian cancer patients 0.574798 ovarian cancer trials 0.513542 Ovarian Cancer Registry 0.525648 ovarian cancer 0.976385 oncology group study 0.500359 advanced ovarian epithelial 0.508108 ovarian carcinoma 0.617715 Hereditary ovarian cancer 0.541701 Natl Cancer Inst 0.533435 Clin Cancer Res 0.471625 Gynecol Oncol 0.499118 ovarian carcinoma patients 0.50527	et al. 0.626141 gynecologic oncology group 0.583453 Lancet Oncol 0.480848 refractory ovarian cancer 0.508349 ovarian cancer—is 0.495704 ovarian cancers 0.496625 II-IV ovarian cancer 0.51385 advanced ovarian carcinoma 0.5343 ovarian epithelial cancer 0.539908 residual ovarian cancer 0.518325 epithelial ovarian cancer 0.803483 ovarian cancer susceptibility 0.533409 Brady MF 0.481715 sporadic ovarian cancer 0.521614 Abstract 0.644778 Clin Oncol 0.718243 platinum-sensitive ovarian cancer 0.536106 BRCA2-associated ovarian cancer 0.521842 recurrent ovarian cancer 0.527704 serous ovarian cancer 0.529665 Ovarian Neoplasm Group 0.493177 advanced-stage ovarian cancer 0.537713 ovarian cancer screening 0.523447 ovarian cancer syndrome 0.536708	CLICK HERE
1532	National Cancer Institute	Html	en	714-X (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of 714-X as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	peer-reviewed scientific journals 0.887587 follow-up treatment 0.710806 cancer cell growth 0.791188 clinical drug research 0.768994 transplanted lymphoma cells 0.825998 camphor-containing compound 0.745221 -dependent breast cancer 0.78236 Cancer Terms 0.744215 ammonia chloride moiety 0.76714 well-designed clinical trials 0.748928 IND application process 0.779791 normal cellular metabolism 0.86297 cancer information summary 0.831041 markets 714-X worldwide 0.83392 breast adenocarcinoma cells 0.816142 conventional light microscope 0.751864 high-magnification dark-field microscope 0.762305 single daily injection 0.759423 local radiation therapy 0.743305 Investigational New Drug 0.768167 estrone sulfatase activity 0.749881 radiation therapy 0.757461 usual treatment cycle 0.783702 immune system cells 0.780568 dead cells 0.766188	lymphoma tumor models 0.74615 treatment cycles 0.709107 peer-reviewed scientific journal 0.752325 breast cancer cells 0.935858 714-X states 0.744286 tumor cells 0.75621 camphor component 0.757515 secrete growth hormones 0.755571 cancer cells 0.999087 malignant cells 0.759464 lymphosarcoma tumor model 0.750284 714-X treatment. 0.746291 human breast cancer 0.781637 privately funded laboratory 0.780536 normal cells 0.757341 714-X state 0.740311 animal studies 0.738772 cancer development 0.726298 714-X reportedly works 0.811434 3-day rest period 0.75559 natural killer cells 0.815748 quality control procedures 0.767937 camphor vapors 0.863518 Numerous trace elements 0.765609	CLICK HERE
1667	National Cancer Institute	Html	en	Pituitary Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of pituitary tumors.	cancer treatment 0.407234 dexamethasone suppression test 0.394248 pituitary tumors 0.908358 body 0.454559 PDQ cancer information 0.487589 clinical trials 0.725513 cancer information summary 0.446379 clinical trial 0.553145 Invasive pituitary adenomas 0.455827 pituitary tumor 0.646868 treatment clinical trial 0.392398 PDQ Adult Treatment 0.388468 transsphenoidal surgery 0.460842 symptoms 0.386795 NCI PDQ cancer 0.400275 radiation therapy 0.593266 Treatment Editorial Board 0.409955 general cancer information 0.38362 treatment 0.554395 Pituitary Tumors Treatment 0.478882 magnetic resonance imaging 0.396976 hormones 0.440574 non-functioning pituitary tumor 0.50102 pituitary adenomas 0.476474	cancer cells 0.443241 pituitary gland 0.710758 Cancer Information Service 0.384842 pituitary carcinomas 0.478569 hormone 0.451928 treatment clinical trials 0.429229 National Cancer Institute 0.477993 spinal cord 0.43789 growth hormone 0.42514 lower sex drive 0.403907 new treatment 0.437528 drug therapy 0.42565 stereotactic radiation surgery 0.403899 Non-functioning pituitary tumors 0.494237 Benign pituitary adenomas 0.455748 nuclear magnetic resonance 0.398799 thyroid-stimulating hormone 0.404707 extra hormones 0.398825 cancer clinical trials 0.398461 recurrent pituitary tumor 0.483709 cancer information summaries 0.383614 functioning pituitary tumor 0.497093 comprehensive cancer information 0.383142 cancer 0.645719	CLICK HERE
1793	National Cancer Institute	Html	es	La nutrición en el tratamiento del cáncer (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y manejo de los problemas de nutrición que se presentan en pacientes de cáncer.	alimentos quizás 0.370325 PDQ Complicaciones 0.313282 siguientes procedimientos 0.340481 células madre 0.550599 nutrientes clave 0.335265 siguientes elementos 0.365852 siguientes aspectos 0.358365 nutriciónLa terapia 0.324031 siguientes especialistas 0.336855 abundantes calorías 0.314309 azúcar morena 0.306423 apoyo nutricional parenteral 0.676801 alimentos nombre 0.30449 plantas crucíferas 0.309965 nutriciónLos pacientes 0.345324 siguientes preguntas 0.30436 folleto consejos 0.305431 saliva espesa 0.32646 dentaduras postizas 0.314487 suficiente aire 0.303863 La nutrición 0.791013 paciente coma 0.327504 parenteralLa nutrición parenteral 0.367865	nutriciónLa radioterapia 0.32699 Nutrición enteralLa 0.344949 Fideos macarrones 0.304814 paciente debilidad 0.352763 nutriciónLa quimioterapia 0.324928 siguientes problemas 0.328941 abundantes proteínas 0.312201 abundante cantidad 0.303969 pequeñas cantidades 0.366387 suficientes calorías 0.337397 sección boca 0.313815 queso crema 0.306383 suficientes proteínas 0.348155 suficientes alimentos 0.437599 suficientes nutrientes 0.304871 estado nutricional ayuda 0.362928 huevos rellenos 0.30608 siguientes logros 0.337047 nutrición parenteral 0.929054 horarios fijos 0.305496 siguientes propósitos 0.338729 cuidado paliativo 0.310231	CLICK HERE
1813	National Cancer Institute	Html	es	Tratamiento del cáncer de recto (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de recto.	Lippincott Williams 0.308061 Compton CC 0.323954 Adults With Colorectal 0.312555 American Cancer Society 0.329394 Cancer mortality 0.316629 Stewart AK 0.306622 CA Cancer 0.343818 local recurrence 0.307246 Cancer Res 0.329381 DeVita VT Jr 0.315048 colorectal cancer 0.983517 intergroup trial int-0089 0.308552 ecografía endorrectal 0.343803 recto combinados 0.312354 Estados Unidos 0.30658 Natl Cancer Inst 0.352599 ColoRectal Cancer Group 0.324874 after curative resection 0.309771 estadificación tnm 0.312196 survival is 0.306383 Colorectal Dis 0.319303 patients with 0.357576 Rosenberg SA 0.307503 Tepper JE 0.30821 Lawrence TS 0.307635	pT3-pT4 colorectal 0.31012 circumferential resection margin 0.307642 Dis Colon Rectum 0.337841 Cancer Facts 0.317459 Curr Probl Cancer 0.317023 after curative 0.310413 quimiorradioterapia preoperatoria 0.311684 Cancer Staging Manual 0.327552 Hereditary Cancer Syndromes 0.316342 Surg Oncol 0.34804 PDQ Tratamiento 0.318445 Cancer invasion 0.315672 9th ed 0.3084 Gastrointestinal Tumor Study 0.307946 Clin Oncol 0.415435 Greene FL 0.306448 recto mide 0.312331 colorectal carcinoma 0.311099 systematic review 0.307729 sección cáncer 0.306733 large scale adjuvant 0.307848 recto medio 0.309555 with colorectal cancer 0.394477 cancer incidence 0.328606	CLICK HERE
3602	National Cancer Institute	Html	en	Improved Strategies for Cancer Prevention and Early Detection	The prevention of cancer and the development of more effective strategies to detect cancer precursors and early stage cancers, when treatment may be most effective, remain critical goals.	cancer treatment 0.540152 anal cancer incidence 0.625627 noncervical cancers 0.552703 preventive HCV vaccine 0.546412 research 0.535928 HPV-positive oropharyngeal cancers 0.555563 cancer biomarker discovery 0.573956 cancer develops 0.60048 cancer biomarker development 0.580329 early pancreatic disease 0.537001 smear-based cervical cancer 0.616538 chronic HCV infection 0.559892 colorectal cancer 0.576235 patients 0.541815 cervical cancer screening 0.699176 cervical cancers 0.57226 cervical cancer 0.761077 HPV vaccine program 0.571212 chronic HBV infection 0.541902 cancers 0.616554 HPV-positive oropharyngeal cancer 0.594068 oncogenic HPV types 0.574039 infectious EBV particles 0.546363 invasive anal cancer 0.592328 United States 0.811567	HCV infection 0.652225 pancreatic cancer precursor 0.587151 percent 0.591951 transfusion-related HCV infection 0.564422 pancreatic cancer 0.645751 precursor lesions 0.541991 common cancer 0.538917 pancreatic cancer cells 0.595973 virus-like particles 0.540706 early cancer detection 0.576023 disease 0.540607 healthy donors 0.556987 persistent HPV infection 0.586925 breast cancer 0.583768 liver cancer mortality 0.588652 late-stage cancer 0.546609 HPV infection 0.707275 cancer risk 0.57351 lung cancer incidence 0.625104 cancer 0.986132 liver cancer 0.648599 Earlier cancer detection 0.569503 EBV infection 0.614356 cancer incidence 0.636488	CLICK HERE
15486	National Cancer Institute	Html	es	Delirio	¿Qué es delirio? Delirio es un estado mental confuse. Se explican las causas de delirio, formas de tratarlo y preguntas para hacer al doctor.	delirio hiperactivo 0.974791		CLICK HERE
15633	National Cancer Institute	Html	en	Step 1: Application Development & Submission	There are nine research grant application types, each with specific procedures. Learn more about developing, submitting, and tracking a cancer research grant application.	small project application 0.562018 grant application types 0.615791 Funding Opportunity Announcement 0.657432 grant applications 0.709584 institution business official 0.474155 Grants.gov Tracking Number 0.523008 ongoing extramural activity 0.49934 NIH’s Application 0.521892 Grants.gov Registration 0.46434 application requirements 0.476818 Administrative Supplement Request 0.466071 specific receipt date 0.531978 grant type 0.487204 specific IC program 0.505666 peer review processes 0.498397 prior approval 0.560178 well-defined scientific area 0.49086 eRA Commons 0.962876 receipt date 0.604332 Electronic grant applications 0.606906 NIH Guide 0.481058 program announcement 0.579666	NCI Grant Policies 0.586226 sam registration 0.473955 scientific peer review 0.497797 Small Business Innovation 0.484684 application status changes—the 0.535723 NCI Funding Opportunities 0.538102 NIH 0.523095 recent budget project 0.476777 Scientific Review Group 0.50345 NCI RFA 0.467797 application submission deadline 0.550381 grant support 0.469498 important application basics 0.5838 strong application 0.469473 application 0.872468 application cycles 0.489855 final assembled application 0.53419 additional prior approval 0.492691 grant application 0.737304 standing receipt date 0.526741 Small Business Technology 0.489507	CLICK HERE
15712	National Cancer Institute	Html	es	Desigualdades en salud por cáncer	El NCI está trabajando para entender y responder a las desigualdades en salud por cáncer, como lo son los índices más altos de mortalidad, menos frecuencia en el uso de exámenes de detección comprobados e índices más altos en el diagnóstico de cánceres avanzados en ciertos grupos de la población en comparación con otros.	maneras—desde investigación 0.583129 Cancer Health Equity 0.613363 NCI compartirán bioespecímenes 0.668631 representación en investigación 0.519297 simple documentación 0.53423 muertes prematuras 0.553886 Continuing Umbrella 0.5389 baja representación 0.511204 complejo sistema 0.519795 Asociación Americana 0.686768 programa partnerships 0.505377 atención sanitaria.  cambios 0.67163 seguro médico 0.780854	Research Experiences 0.529795 Instituto Nacional 0.508992 darán forma 0.516718 Estados Unidos.  0.527127 programa cure 0.518838 múltiples barreras 0.536273 Ascendencia Africana 0.530463 Affordable Care Act 0.638752 Estudio Genético 0.515417 cabo estudios 0.5272 continuo académico 0.516307 cáncer—desde acceso 0.547555 Sociedad Americana Contra El Cáncer 0.968768	CLICK HERE
15881	National Cancer Institute	Html	es	Cardo mariano (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.	único antídoto 0.424085 efectos anticancerígenos directos 0.448877 Centro Nacional 0.438096 Silybum marianum 0.427074 múltiples transfusiones 0.423127 New Hampshire Avenue 0.426894 nombres legalon 0.423938 Edad Media 0.422184 Drug Administration 0.416696 leucemia linfoblástica aguda 0.553126 NCI Best Case 0.448513 vía oral 0.423383 datos bibliográficos pubmed 0.428946 larga historia 0.423907 siguientes preguntas 0.415539 Comisión Alemana E 0.439565 siguientes riesgos 0.419206 antiguos griegos 0.424579 Instituto Nacional 0.546708 raras ocasiones 0.42203	Salud Complementaria 0.459564 Visuals Online 0.419468 complementarias revisa 0.427116 siguientes efectos 0.430145 Physician Data Query 0.511692 Estados Unidos 0.98357 gobierno alemán 0.419217 libre uso 0.423309 cabo estudios 0.428996 cuello uterino 0.423208 cardo lechero 0.591346 nombre botánico 0.423968 Santa María 0.422174 página manejo 0.418166 cardo mariano ayuda 0.71222 ¿El tratamiento 0.434743 ¿Los beneficios 0.41683 juntos cam 0.416094 Series Program 0.416547 medicina complementaria 0.871118	CLICK HERE